Impact of CYP4F2 rs2108622 Variant on Warfarin Dose Requirement in Indian Patients

被引：0
|
作者：
Shah, S. [1 ]
Paradkar, M. [1 ]
Natarajan, S. [1 ]
Ponde, C. [2 ]
Rajani, R. [2 ]
Jijina, F. [3 ]
Gursahani, R. [4 ]
Ashavaid, T. [5 ]
机构：
[1] PD Hinduja Hosp & MRC, Res Labs, Mumbai, Maharashtra, India
[2] PD Hinduja Hosp & MRC, Dept Cardiol, Mumbai, Maharashtra, India
[3] PD Hinduja Hosp & MRC, Dept Clin Hematol, Mumbai, Maharashtra, India
[4] PD Hinduja Hosp & MRC, Dept Neurol, Mumbai, Maharashtra, India
[5] PD Hinduja Hosp & MRC, Dept Lab Med, Mumbai, Maharashtra, India
来源：
JOURNAL OF MOLECULAR DIAGNOSTICS | 2019年 / 21卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
P009
引用
收藏
页码：S19 / S20
页数：2
相关论文
共 50 条
  • [1] Influence of CYP4F2 rs2108622 (V433M) on Warfarin Dose Requirement in Asian Patients
    Singh, Onkar
    Sandanaraj, Edwin
    Subramanian, Koilan
    Lee, Lai Heng
    Chowbay, Balram
    DRUG METABOLISM AND PHARMACOKINETICS, 2011, 26 (02) : 130 - 136
  • [2] Impact of CYP4F2 rs2108622 on the Stable Warfarin Dose in an Admixed Patient Cohort
    Perini, J. A.
    Struchiner, C. J.
    Silva-Assuncao, E.
    Suarez-Kurtz, G.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2010, 87 (04) : 417 - 420
  • [3] CYP4F2 genetic variant (rs2108622) significantly contributes to warfarin dosing variability in the Italian population
    Borgiani, P.
    Ciccacci, C.
    Forte, V.
    Sirianni, E.
    Novelli, L.
    Bramanti, P.
    Novelli, G.
    PHARMACOGENOMICS, 2009, 10 (02) : 261 - 266
  • [4] CYP4F2 rs2108622: a minor significant genetic factor of warfarin dose in Han Chinese patients with mechanical heart valve replacement
    Cen, Han-Jing
    Zeng, Wu-Tao
    Leng, Xiu-Yu
    Huang, Min
    Chen, Xiao
    Li, Jia-Li
    Huang, Zhi-Ying
    Bi, Hui-Chang
    Wang, Xue-Ding
    He, Yan-Ling
    He, Fan
    Zhou, Rui-Na
    Zheng, Qi-Shan
    Zhao, Li-Zi
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2010, 70 (02) : 234 - 240
  • [5] Correlation between Rs2108622 Locus of CYP4F2 Gene Single Nucleotide Polymorphism and Warfarin Dosage in Iranian Cardiovascular Patients
    Khosropanah, Shahdah
    Faraji, Seyed Nooreddin
    Habibi, Hamzeh
    Yavarian, Majid
    Mansoori, Roohollah
    Haghpanah, Sezaneh
    IRANIAN JOURNAL OF PHARMACEUTICAL RESEARCH, 2017, 16 (03): : 1238 - 1246
  • [6] Correlation between CYP4F2 gene rs2108622 polymorphism and susceptibility to ischemic stroke
    Meng, Chong
    Wang, Juan
    Ge, Wei-Ning
    Tang, Shao-Can
    Xu, Guang-Ming
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2015, 8 (09): : 16122 - 16126
  • [7] Association of the CYP4F2 rs2108622 genetic polymorphism with hypertension: a meta-analysis
    Luo, X. -H.
    Li, G. -R.
    Li, H. -Y.
    GENETICS AND MOLECULAR RESEARCH, 2015, 14 (04): : 15133 - 15139
  • [8] Association Between the CYP4F2 Gene rs1558139 and rs2108622 Polymorphisms and Hypertension: A Meta-Analysis
    Geng, Huixia
    Li, Bo
    Wang, Yanmei
    Wang, Lai
    GENETIC TESTING AND MOLECULAR BIOMARKERS, 2019, 23 (05) : 342 - 347
  • [9] CYP4F2 genetic variant alters required warfarin dose
    Caldwell, Michael D.
    Awad, Tarif
    Johnson, Julie A.
    Gage, Brian F.
    Falkowski, Mat
    Gardina, Paul
    Hubbard, Jason
    Turpaz, Yaron
    Langaee, Taimour Y.
    Eby, Charles
    King, Cristi R.
    Brower, Amy
    Schmelzer, John R.
    Glurich, Ingrid
    Vidaillet, Humberto J.
    Yale, Steven H.
    Zhang, Kai Qi
    Berg, Richard L.
    Burmester, James K.
    BLOOD, 2008, 111 (08) : 4106 - 4112
  • [10] 老年患者CYP4F2(rs2108622)基因多态性对华法林剂量的影响
    谭明娟
    崔薇薇
    陈枫
    梅燕萍
    高应东
    国际检验医学杂志, 2014, 35 (11) : 1400 - 1401+1404
12345